As of April 1st, 2021 EJNMMI Research has a new Editor-in-Chief. Please welcome Wim J. G. Oyen.
Thank you very much to Angelika Bischof Delaloye for establishing EJNMMI Research as Editor-in-Chief since the launch of the journal in 2011.
Nuclear medicine is a vibrant and rapidly developing field in biomedical research. Within the family of EJNMMI journals, EJNMMIresearch focuses on translational research, aiming to be the bridge between basic and and clinical research in nuclear medicine, molecular imaging as well radioligand-based therapy and related concepts of targeted therapies. EJNMMIresearch positions itself at the cross-roads of innovative research in biology, genetics, immunology, medicine, radiochemistry, radiopharmacy, radiophysics, dosimetry and instrumentation.
EJNMMIresearch encourages submission of original, cutting-edge basic, translational and early clinical research. This includes rapid communication of proof-of-concept or even preliminary findings. EJNMMIresearch also welcomes submission of state-of-the-art educational papers, reviews and short communications. Editorials and Letters-to-the-Editor are an integral and indispensable part of lively interaction within the scientific community to exchange thoughts and opinions. Occasionally, case reports will also be considered. EJNMMIresearch’s fully Open Access model of publication facilitates rapid processing after rigorous peer review of the submitted manuscripts.
As an established member of the five Journals in the EJNMMI family of Journals (www.springeropen.com/p/nuclear-medicine), EJNMMIresearch also encourages high-quality submissions, which are within the scope of EJNMMIresearch, but cannot be acccomodated by the other Journals in the family. Conversely, original manuscripts not accepted by EJNMMIresearch may prove to be a better fit with other Journals in the family.
On behalf of the entire EJNMMIresearch team, thank you for considering EJNMMIresearch as the journal to publish your research.
Wim J.G. Oyen, Editor-in-Chief
Humanitas University Milan, Italy and Rijnstate Arnhem, The Netherlands